TruGenomix Health will launch a revolution in treatment for post-traumatic stress disorder (PTSD), offering better identification of the condition and targeted, individualized treatment options.
TruGenomix Health is the brainchild of two veterans with a passion for medical research and a desire to help their fellow service members and veterans. Yusuf Henriques served as a Combat Medic in the US Army. When his military career was cut short due to service related injuries, he returned to school to earn a Bachelor’s degree in Biology/Chemistry and began a successful career in the healthcare industry. Charles Cathlin, an Air Force Academy graduate, served as a Bioenvironmental Engineer. After his stint in the Air Force, he joined the Public Health Service and completed twenty-one years in uniform.
The two met in 2006 as scientific reviewers in the FDA’s Center for Devices and Radiological Health and bonded over a shared desire to improve medical treatment for veterans and entrepreneurs’ frustration at the pace of innovation. Because they shared the same vision, passion and commitment to protecting the public health, they combined their more than four decades of military, medical and federal experience to form TruGenomix Health, LLC, in 2015.
TruGenomix Health is rooted in both men's devotion to supporting our nation's warfighters and veterans. The company’s mission is to bring groundbreaking biotechnology to bear on the problem of PTSD, enabling the Department of Defense to carry out its mission to provide the military forces needed to protect the security of our country and allowing the Department of Veterans Affairs to more fully fulfill President Lincoln's promise "to care for him who shall have borne the battle…” As a service-disabled, veteran-owned small business, the goal of TruGenomix Health is to provide solutions that improve the lives, health and future of the members of our military, our veterans and their families.